Therapeutic plasmapheresis and haemostatic system.

Folia Haematol Int Mag Klin Morphol Blutforsch

Institute of Pathological and Clinical Biochemistry, Hospital of Humboldt, University Berlin, GDR.

Published: April 1989

The influence of therapeutic plasmapheresis by using membrane filter was investigated in 38 patients with 108 procedures. Fibrinogen and AT III reached most pronounced reduced levels in the course of three plasma exchanges while factors II, V, X, Hepato-Quick, Reptilase time and thrombocyte count remained relatively unchanged. There was no bleeding or thrombotic event in the patients. We concluded that at least determination of fibrinogen and AT III levels must be done just prior to each individual plasmapheresis to prevent dangerous imbalances in haemostatic system.

Download full-text PDF

Source

Publication Analysis

Top Keywords

therapeutic plasmapheresis
8
haemostatic system
8
fibrinogen iii
8
plasmapheresis haemostatic
4
system influence
4
influence therapeutic
4
plasmapheresis membrane
4
membrane filter
4
filter investigated
4
investigated patients
4

Similar Publications

Background And Objectives: Serum immunoglobulin G (IgG) and total protein are used to monitor plasmapheresis donor safety. However, there is a lack of information from large donor cohorts to determine the best use of these measurements.

Materials And Methods: We identified 230,144 plasmapheresis donors making their first donation between 1 July 2020 and 31 March 2024.

View Article and Find Full Text PDF

The simultaneous occurrence of vasculitic glomerulonephritis and membranous nephropathy is unusual. We report two cases that presented to our outpatient department with rapidly progressive renal failure. On evaluation, in one patient, anti-myeloperoxidase (MPO) titers were high, and renal biopsy was suggestive of concurrent necrotizing and diffuse crescentic anti-MPO anti-neutrophil cytoplasmic antigen-associated glomerulonephritis with the circumferential cellular crescent formation and membranous glomerulopathy.

View Article and Find Full Text PDF

Thrombotic microangiopathy (TMA) is a severe condition characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end-organ damage, often involving the kidneys. Complement-mediated hemolytic uremic syndrome (cHUS), a rare form of TMA, arises from dysregulated alternative complement pathway activation, frequently due to genetic mutations. We report the case of a 23-year-old male presenting with TMA secondary to a heterozygous mutation in the membrane cofactor protein (MCP/CD46) gene.

View Article and Find Full Text PDF

Background: This study examines the role and effectiveness of double filtration plasmapheresis (DFPP) in managing hyperlipidemiclipidemic acute pancreatitis (HLAP).

Methods: Comparative analysis was conducted between two groups: one treated with DFPP and one without. Comparative parameters included blood lipid levels, inflammatory factors, vital signs, disease severity scores, and complication rates.

View Article and Find Full Text PDF

Anti-glomerular basement membrane disease is a rare small vessel vasculitis caused by the deposition of immunoglobulin G (IgG) autoantibodies in the basement membrane of glomerular capillaries and lung alveoli, leading to rapidly progressive renal failure and/or alveolar hemorrhage. We report the case of an 83-year-old female patient presenting with uremic symptoms, rapidly progressive kidney failure, and a high titer of anti-glomerular basement membrane antibodies. Given the urgent need for kidney replacement therapy, the substantial fibrosis and glomerular scarring observed in the kidney biopsy suggesting a chronic process, and the absence of pulmonary involvement, neither immunosuppressive treatment nor plasmapheresis was initiated, since a low likelihood of a favorable response to these interventions was expected.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!